Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2014 16:00 ET | Source: Parnell Pharmaceuticals Holdings Ltd

Parnell Pharmaceuticals Holdings Ltd Announces Fiscal Year 2014 Financial Results

OVERLAND PARK, Kan., Sept. 15, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
September 10, 2014 15:40 ET | Source: Parnell Pharmaceuticals Holdings Ltd

Parnell to Report Fiscal Year 2014 Financial Results September 15, 2014

OVERLAND PARK, Kan., Sept. 10, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
September 08, 2014 17:31 ET | Source: Parnell Pharmaceuticals Holdings Ltd

Parnell Appoints US-Based Independent Directors Phyllis Gardner, M.D., and David L. Greenwood to Its Board of Directors

OVERLAND PARK, Kan., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN) today announced that it had appointed U.S. based Phyllis Gardner, MD, and David L. Greenwood...
September 03, 2014 18:06 ET | Source: Parnell Pharmaceuticals Holdings Ltd

Parnell Announces Results From the Successful Efficacy Study for Zydax(R)

OVERLAND PARK, Kan., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN) today announced the results from a successful, large-scale efficacy study of Zydax, for the...